Skip to content
DraconiticResearch
Search Sources API
182,544 studies31 sourcesUpdated 57 min ago
PreprintCC BY-NC-NDbioRxiv

Mycobacterium tuberculosis inactivates host oxysterols to impair macrophage cholesterol homeostasis

4 more authors
  1. 1Washington University in St. Louis School of Medicine

Abstract

Host oxysterols coordinate macrophage cholesterol homeostasis and antimicrobial defense, but whether pathogens directly target oxysterol signaling is unknown. Here, we identify pathogen-mediated enzymatic oxysterol inactivation as a mechanism by which Mycobacterium tuberculosis (Mtb) subverts host cholesterol metabolism. Mtb oxidizes the endogenous oxysterols 27-hydroxycholesterol (27-HC) and 3{beta}-hydroxycholest-5-enoic acid (3{beta}-HCA) into 3-oxo-{Delta}4 metabolites. Sputum lipidomics across TB cohorts on three continents revealed an active-disease signature characterized by 27-HC depletion and accumulation of 27-hydroxycholest-4-en-3-one (27-HCO) and 3-oxocholest-4-enoic acid (3O-CA), which normalized with treatment. In infected human macrophages, Mtb 3{beta}-hydroxysteroid dehydrogenase (3{beta}-Hsd) generated 27-HCO. Unlike their parent oxysterols, 27-HCO and 3O-CA did not activate liver X receptor (LXR), and 3O-CA failed to suppress sterol regulatory element-binding protein 2 (SREBP2) target genes. Accordingly, 3{beta}-Hsd-deficient Mtb did not induce macrophage cholesterol retention, a phenotype restored by LXR antagonism. Thus, Mtb enzymatically inactivates host oxysterols, disrupting macrophage cholesterol homeostasis and generating treatment-responsive metabolic signatures in human TB.

Related

  1. Diagnostic accuracy of Mycobacterium tuberculosis antigen-induced interferon-γ-inducible protein 10 for latent tuberculosis infection among high-risk groups: a systematic review and meta-analysis
    Lan Huang, Yong Hu, Qian Mao +2
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  2. Mycobacterium tuberculosis requires riboflavin biosynthesis for survival in the host
    A. M. Block, S. B. Namugenyi, A. D. Tischler
    bioRxivPreprintAll rights reservedFull textMicrobiologybioRxiv
  3. Rv2061c, a Putative F420-Dependent Oxidoreductase, is Required for Tolerance to Malachite Green and Other Antimicrobials and Oxidative Stress Protection in Mycobacterium tuberculosis
    D. Rifat, T. R. Ioerger, E. L. Nuermberger
    bioRxivPreprintAll rights reservedFull textMicrobiologybioRxiv
  4. PIM6 Induces Tolerance and Confers Protection against Mycobacterium tuberculosis in Primary Macrophages
    M. S. Gower, L. Kleberg, C. S. Silva +5
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv
  5. ESX-5 paralog deletions in Mycobacterium tuberculosis alter macrophage cytokine signaling and bacterial heavy metal response
    Austin M. Haynes, Sara B. Cohen, Venkata Aparajita Pesaladinne +4
    iSciencePeer-reviewedCC BY-NC-ND 4.0Molecular biology & gene regulationImmunologyCell PressCrossref
BibTeX
@misc{roth2026mycobacterium,
  title = {{Mycobacterium tuberculosis inactivates host oxysterols to impair macrophage cholesterol homeostasis}},
  author = {A. Roth and M. Ali Asgari and P. Chandra and J. Muhammad and A. Lopez and S. Bhattacharya and I. A. Williams and B. Edelson and C. W. Goss and D. I. Kotov and M. Qian and D. F. Covey and X. Jiang and W. J. Griffiths and Y. Wang and J. A. Philips},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.04.756586},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.04.756586v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Mycobacterium tuberculosis inactivates host oxysterols to impair macrophage cholesterol homeostasis
AU  - A. Roth
AU  - M. Ali Asgari
AU  - P. Chandra
AU  - J. Muhammad
AU  - A. Lopez
AU  - S. Bhattacharya
AU  - I. A. Williams
AU  - B. Edelson
AU  - C. W. Goss
AU  - D. I. Kotov
AU  - M. Qian
AU  - D. F. Covey
AU  - X. Jiang
AU  - W. J. Griffiths
AU  - Y. Wang
AU  - J. A. Philips
PY  - 2026
DA  - 2026/10/04
PB  - bioRxiv
DO  - 10.64898/2026.10.04.756586
UR  - https://www.biorxiv.org/content/10.64898/2026.10.04.756586v1
AB  - Host oxysterols coordinate macrophage cholesterol homeostasis and antimicrobial defense, but whether pathogens directly target oxysterol signaling is unknown. Here, we identify pathogen-mediated enzymatic oxysterol inactivation as a mechanism by which Mycobacterium tuberculosis (Mtb) subverts host cholesterol metabolism. Mtb oxidizes the endogenous oxysterols 27-hydroxycholesterol (27-HC) and 3{beta}-hydroxycholest-5-enoic acid (3{beta}-HCA) into 3-oxo-{Delta}4 metabolites. Sputum lipidomics across TB cohorts on three continents revealed an active-disease signature characterized by 27-HC depletion and accumulation of 27-hydroxycholest-4-en-3-one (27-HCO) and 3-oxocholest-4-enoic acid (3O-CA), which normalized with treatment. In infected human macrophages, Mtb 3{beta}-hydroxysteroid dehydrogenase (3{beta}-Hsd) generated 27-HCO. Unlike their parent oxysterols, 27-HCO and 3O-CA did not activate liver X receptor (LXR), and 3O-CA failed to suppress sterol regulatory element-binding protein 2 (SREBP2) target genes. Accordingly, 3{beta}-Hsd-deficient Mtb did not induce macrophage cholesterol retention, a phenotype restored by LXR antagonism. Thus, Mtb enzymatically inactivates host oxysterols, disrupting macrophage cholesterol homeostasis and generating treatment-responsive metabolic signatures in human TB.
ER  -